Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023

SELL
$62.39 - $113.8 $8.7 Million - $15.9 Million
-139,397 Reduced 57.34%
103,724 $11.8 Million
Q3 2022

Nov 14, 2022

BUY
$58.92 - $84.67 $1.7 Million - $2.44 Million
28,844 Added 13.46%
243,121 $15 Million
Q2 2022

Aug 10, 2022

SELL
$79.4 - $116.36 $2.04 Million - $2.98 Million
-25,648 Reduced 10.69%
214,277 $17.1 Million
Q1 2022

May 10, 2022

BUY
$86.42 - $109.81 $6.82 Million - $8.66 Million
78,862 Added 48.96%
239,925 $25.2 Million
Q4 2021

Feb 14, 2022

BUY
$98.56 - $119.91 $1.26 Million - $1.54 Million
12,818 Added 8.65%
161,063 $17.4 Million
Q3 2021

Nov 15, 2021

SELL
$91.91 - $110.37 $7.32 Million - $8.78 Million
-79,594 Reduced 34.93%
148,245 $16.2 Million
Q2 2021

Aug 10, 2021

SELL
$86.24 - $95.92 $3.69 Million - $4.1 Million
-42,792 Reduced 15.81%
227,839 $21.3 Million
Q1 2021

May 14, 2021

SELL
$71.83 - $95.48 $1.04 Million - $1.38 Million
-14,415 Reduced 5.06%
270,631 $24.9 Million
Q4 2020

Feb 11, 2021

BUY
$67.0 - $84.39 $1.39 Million - $1.75 Million
20,690 Added 7.83%
285,046 $20.9 Million
Q3 2020

Nov 13, 2020

BUY
$55.23 - $79.93 $11.8 Million - $17 Million
212,977 Added 414.52%
264,356 $20.5 Million
Q2 2020

Aug 12, 2020

SELL
$30.2 - $56.98 $3.33 Million - $6.28 Million
-110,285 Reduced 68.22%
51,379 $2.86 Million
Q1 2020

May 13, 2020

SELL
$24.87 - $38.56 $815,114 - $1.26 Million
-32,775 Reduced 16.86%
161,664 $4.79 Million
Q4 2019

Feb 13, 2020

SELL
$25.43 - $36.67 $4.31 Million - $6.22 Million
-169,678 Reduced 46.6%
194,439 $7.04 Million
Q3 2019

Nov 13, 2019

BUY
$23.0 - $27.97 $3.52 Million - $4.28 Million
152,939 Added 72.42%
364,117 $9.92 Million
Q2 2019

Aug 09, 2019

BUY
$22.81 - $28.48 $4.82 Million - $6.01 Million
211,178 New
211,178 $5.08 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Nicholas Investment Partners, LP Portfolio

Follow Nicholas Investment Partners, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Investment Partners, LP, based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Investment Partners, LP with notifications on news.